Fusion Pharmaceuticals Strengthens Actinium Supply with Onsite Isotope Production through Expanded BWXT Medical Collaboration Nov 16, 2023 06:45AM
BWX Technologies to Announce Third Quarter 2023 Results on Wednesday, November 1 Oct 2, 2023 04:05PM
BWX Technologies (BWXT) and Crowley Debut Nuclear Power Generation Vessel Concept Sep 20, 2023 06:46AM
BWXT, Crowley Debut Nuclear Power Generation Vessel Concept Sep 20, 2023 06:45AM
Crowley, BWXT Debut Nuclear Power Generation Vessel Concept Sep 20, 2023 06:45AM
View Older Stories

Sep 12, 2023 06:45AM BWX Technologies (BWXT) Awarded Contract to Evaluate Microreactor Deployment for State of Wyoming
Sep 12, 2023 06:45AM BWXT Awarded Contract to Evaluate Microreactor Deployment for State of Wyoming
Aug 30, 2023 06:45AM BWX Technologies (BWXT) to Manufacture HALEU Feedstock for Advanced Reactors
Aug 30, 2023 06:45AM BWXT to Manufacture HALEU Feedstock for Advanced Reactors
Aug 3, 2023 04:05PM BWX Technologies Reports Second Quarter 2023 Results
Aug 2, 2023 04:30PM BWXT Awarded an Engineering Contract from TerraPower for the Natrium™ Demonstration Project
Jul 26, 2023 09:11AM BWX Technologies (BWXT) to Provide Nuclear Reactor Engine and Fuel for DARPA Space Project
Jul 26, 2023 09:11AM BWXT to Provide Nuclear Reactor Engine and Fuel for DARPA Space Project
Jun 27, 2023 04:15PM BWX Technologies to Announce Second Quarter 2023 Results on Thursday, August 3
May 8, 2023 04:06PM BWX Technologies Reports First Quarter 2023 Results
Apr 17, 2023 04:30PM BWX Technologies (BWXT) Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site
Apr 17, 2023 04:30PM BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site
Apr 10, 2023 04:31PM BWX Technologies (BWXT) Subsidiary Awarded $428 Million Contract for Uranium Conversion and Purification Services
Apr 10, 2023 04:30PM BWXT Subsidiary Awarded $428 Million Contract for Uranium Conversion and Purification Services
Apr 5, 2023 04:05PM BWX Technologies to Announce First Quarter 2023 Results on Monday, May 8
Mar 21, 2023 06:45AM BWX Technologies (BWXT) Awarded Engineering Contract from GE Hitachi for BWRX-300 Small Modular Reactor
Mar 21, 2023 06:45AM BWXT Awarded Engineering Contract from GE Hitachi for BWRX-300 Small Modular Reactor
Mar 2, 2023 04:51PM BWXT Releases 2023 Sustainability Report
Feb 23, 2023 04:06PM BWX Technologies Reports Fourth-Quarter and Full-Year 2022 Results, Initiates 2023 Guidance and Increases Quarterly Cash Dividend
Feb 1, 2023 06:45AM BWXT Medical and Laurentis Complete Key Tc-99m Generator Program Milestone
Jan 26, 2023 09:34AM BWX Technologies to Announce Fourth Quarter and Full-Year 2022 Results on Thursday, February 23
Jan 5, 2023 05:01PM Fusion Pharmaceuticals (FUSN) and BWXT (BWXT) Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
Jan 5, 2023 05:00PM Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
Jan 5, 2023 05:00PM Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
Jan 4, 2023 07:15AM BWXT Promotes Chip Whitford to Senior Vice President and General Counsel
Dec 7, 2022 02:00PM BWX Technologies (BWXT) Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
Dec 7, 2022 02:00PM BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
Nov 7, 2022 04:10PM BWX Technologies Reports Third Quarter 2022 Results
Nov 2, 2022 07:45AM BWXT to Participate in Upcoming Investor Conferences
Oct 12, 2022 04:30PM BWXT Closes Amended and Restated Credit Agreement
Oct 12, 2022 11:00AM BWX Technologies to Announce Third Quarter 2022 Results on Monday, November 7
Sep 13, 2022 04:06PM BWX Technologies (BWXT) Submits Tc-99m Generator New Drug Application to FDA
Sep 13, 2022 04:05PM BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
Aug 22, 2022 06:45AM BWXT Names Robert Duffy as Chief Administrative Officer
Aug 8, 2022 04:10PM BWX Technologies Reports Robust Second Quarter 2022 Results; Increases 2022 Revenue and Adjusted EBITDA(1) Guidance
Jul 27, 2022 06:47AM BWX Technologies (BWXT) Appoints Sharon H. Smoot as President of Nuclear Operations Group
Jul 27, 2022 06:45AM BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
Jul 14, 2022 08:00AM BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8
Jul 5, 2022 06:45AM BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
Jun 27, 2022 06:45AM BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
Jun 13, 2022 06:47AM BWX Technologies (BWXT) and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
Jun 13, 2022 06:45AM BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
Jun 9, 2022 06:45AM BWX Technologies (BWXT) to Build First Advanced Microreactor in the US
Jun 9, 2022 06:45AM BWXT to Build First Advanced Microreactor in United States
May 9, 2022 04:10PM BWX Technologies Reports First Quarter 2022 Results
May 3, 2022 04:53PM BWX Technologies (BWXT) Appoints Jan A. Bertsch as Board Chair
May 3, 2022 04:30PM BWXT Appoints Jan A. Bertsch as New Chair of Board of Directors
Mar 30, 2022 04:36PM BWX Technologies to Announce First Quarter 2022 Results on Monday, May 9 and Issues Interim Update on Key Initiatives
Feb 28, 2022 06:45AM BWXT Releases 2022 Sustainability Report
Feb 23, 2022 06:48AM BWX Technologies (BWXT) Awarded $1B in Naval Nuclear Propulsion Program Options
View Older Stories